Big Pharma's Get-Out-of-Jail-Free Card
Why It's Time to Repeal the Shield [opinion]
Have you ever wondered why you can sue a car manufacturer for a faulty airbag, but you can’t sue a pharmaceutical company for a vaccine that causes harm? It’s a question that cuts to the heart of a long-standing legal protection that has shielded vaccine manufacturers from liability for decades. And now, a new bill in Congress is seeking to tear down that shield.
For too long, Big Pharma has operated with a level of immunity that few other industries enjoy. This isn’t about being for or against vaccines; it’s about accountability. It’s about ensuring that the same rules apply to everyone, especially when it comes to products that are mandated or strongly encouraged for public health.
The Shield: A Brief History of the National Childhood Vaccine Injury Act
In 1986, President Ronald Reagan signed the National Childhood Vaccine Injury Act (NCVIA) into law. The primary purpose of the NCVIA was to eliminate the potential financial liability of vaccine manufacturers due to vaccine injury claims, in order to ensure a stable market supply of vaccines. In essence, it was a response to a growing number of lawsuits against vaccine manufacturers, which some feared would lead to vaccine shortages.
To achieve this, the NCVIA created the National Vaccine Injury Compensation Program (NVICP), a federal no-fault system for compensating vaccine-related injuries or death. Instead of suing the vaccine manufacturer in civil court, individuals who believe they have been harmed by a vaccine must file a claim with the NVICP. These claims are heard by special masters in the U.S. Court of Federal Claims.
While the NCVIA was intended to provide a more streamlined and less adversarial process for resolving vaccine injury claims, it has been criticized for creating a system where vaccine manufacturers have little financial incentive to ensure their products are as safe as possible. When a company is shielded from the consequences of its actions, what motivation does it have to improve?
A New Hope: The “End the Vaccine Carveout Act”
This past July, a glimmer of hope emerged. Representative Paul Gosar of Arizona introduced H.R. 4668, the “End the Vaccine Carveout Act.” This bill would do exactly what its name suggests: end the immunity from liability for vaccine manufacturers. This isn’t a radical idea; it’s a common-sense reform that would bring the pharmaceutical industry in line with every other industry in America.
As of October 2025, the bill has been referred to the House Committee on Energy and Commerce and has garnered the support of 29 cosponsors, all of whom are from the Republican party. This growing support signals a building momentum to reconsider the special protections granted to vaccine manufacturers.
Key Sponsors of H.R. 4668:
Rep. Andy Biggs [R-AR-5]
Rep. Lauren Boebert [R-CO-4]
Rep. Tim Burchett [R-TN-2]
Rep. Marjorie Taylor Greene [R-GA-14]
Rep. Thomas Massie [R-KY-4]
Rep. Chip Roy [R-TX-21]
If passed, this bill would allow those who have been injured by vaccines to have their day in court. It would give them the opportunity to hold these massive corporations accountable for the damage their products have caused. It would, in short, restore a measure of justice to a system that has been sorely lacking it.
